Newsmeme!
Discover News you didn't know existed
NASA: Spirit still stuck in Martian sand ... Antacid drugs may lead to dependency … Frozen carbon a climate change threat … Cancer, non-cancer cells have similarities ... Health/Science news from UPI.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 9, 2009) - Allon Therapeutics Inc. (TSX:NPC) today released top-line results from a Phase IIa clinical trial showing that the Company's lead neuroprotective drug candidate, davunetide intranasal (AL-108), has a positive impact on the ability of schizophrenia patients to carry out important activities in their daily lives. Allon said statistically ...
VANCOUVER, BRITISH COLUMBIA-- - Allon Therapeutics Inc. today released top-line results from a Phase IIa clinical trial showing that the Company's lead neuroprotective drug candidate, davunetide intranasal , has a positive impact on the ability of schizophrenia patients to carry out important activities in their daily lives.
Rigel does it quite well, in fact.
Array BioPharma Inc. (NASDAQ: ARRY) announced top-line results from its Phase 1 seven-day dose escalation trial up to 1,200 mg daily of p38 inhibitor, ARRY-797, in healthy volunteers. In addition, the top-line results were announced in a second study, where ARRY-797 was evaluated in a 28-day Phase 1b trial in stable rheumatoid arthritis (RA) patients taking methotrexate.
Researchers, led by Peter Howe, recruited 34 healthy men to participate in their 12-week double-blind, placebo-controlled cross-over trial. The men were randomly assigned to receive a daily dose of 116 mg soy isoflavones, providing 68 mg daidzein, 12 mg genistein, and 36 mg glycitin, or placebo for 6 weeks.
"With this randomised, double-blind, controlled trial we show that an 8-week supplementation with 5.4 g daily of the n-3 PUFA DHA led to a significant clinical improvement of atopic eczema compared with baseline scores," wrote the researchers, led by Margitta Worm from Charite-Universitatsmedizin Berlin.
Would the Cochrane review author recommend salicylate creams to consumers? "I wouldn't waste the money. You might as well rub your skin with a bit of spit."
DALLAS — A single dose of the female hormone estrogen could protect the brain after a traumatic injury, but researchers won't know for sure until they test it on humans.
Rigel's oral medicine, R788, significantly improved the symptoms of rheumatoid arthritis patients in a study compared with a placebo, but as in previous studies high blood pressure emerged as a leading side effect.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |